Trials / Sponsors / PharmAthene, Inc.
PharmAthene, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects Anthrax | Phase 1 | 2010-12-01 |
| Completed | Study of Valortim® (MDX-1303) and Its Selected Formulation Components Percutaneous Use Allergic Reactions | Phase 1 | 2010-07-01 |
| Suspended | Ph1 Study of Valortim and Ciprofloxacin in Humans Anthrax | Phase 1 | 2009-08-01 |
| Terminated | Ph1 Study of Valortim and Doxycycline in Humans Anthrax | Phase 1 | 2009-07-01 |
| Completed | First Time in Human Study of Protexia Intervention for Nerve Agent Exposure | Phase 1 | 2008-09-01 |